Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Topiramate NDC 24979-210 by Twi Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure1 - figure 1

figure1 - figure 1

This text appears to be a chart displaying cumulative rates for time to the first seizure. The chart shows rates at different time intervals, ranging from 0 to 500 days. The rates are represented by percentage values, ranging from 0.00% to 5.0%, which are likely associated with different dosages of a medication called Topamax. The dosages mentioned include 50 mg/day (N=234) and 400 mg/day (N=236). A significant p-value of 0.0002 suggests a statistically significant difference between the two dosages in terms of their effectiveness in preventing seizures.*

figure2 - figure 2

figure2 - figure 2

label 15mg - label 15

label 15mg - label 15

This text appears to be a description of a medication called Topiramate. Each capsule contains 15 mg of the active ingredient, and it should be stored in a tight container at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions to 15°C to 30°C (59°F to 86°F). The capsules are white to off-white, spherical-shaped coated pellets and are marked with "15 mg" on the body and "TWi T210" on the cap. The medication is manufactured by TWi Pharmaceuticals USA, Inc. in Paramus, NJ. The NDC number for the medication is 24979-210-04, and it is available in a package containing 60 capsules. The pharmacist should dispense the accompanying Medication Guide to each patient.*

label 25mg - label 25

label 25mg - label 25

Each capsule of this product contains 25 mg of topiramate, which is used for various medical conditions. It is important to follow the dosage and prescribing information provided in the product literature. The capsules should be kept in a tight container and stored at a temperature between 20° and 25°C (68° to 77°F), with limited excursions allowed. Protection from moisture is recommended, and the product should be kept out of reach of children. The capsules themselves are white to off-white in color, with a spherical shape and a coating. The capsule body is white and opaque, with the marking "25 mg", while the cap is clear and marked as "TWi T211". The product is manufactured by TWi Pharmaceuticals in Taoyuan City, Taiwan, and is distributed by TWi Pharmaceuticals USA, Inc. based in Paramus, NJ. The product is available in a package containing 60 capsules. Pharmacists are directed to dispense the medication guide along with the product to each patient. Unfortunately, the remaining text from the output is not readable and cannot be used to generate a useful description.*

logo - logo 2

logo - logo 2

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.